Student:
"The food was good and prepared
well. The
cooks were patient. If I couldn't
eat something because I wasn't well they would make me
something that I could eat and for that I thank
you.
The grounds are nice and
peaceful.
There is plenty of room to roam when your mind
and body need to pace to keep yourself from freaking
out.
I realized with the help of the staff
at Novus that I needed to go to another program after
leaving here because I'm still not quite ready to go
home. As
much as I wanted to just leave and go home there is a
serious danger of relapsing there even though I feel I'm
ready. I
realized that the time that I was abusing drugs reflects
the time of my recovery. Two weeks of
staying away from the dangers that my home life could
contribute to my relapse isn't equivalent to the years
and years of abuse. I succeeded in
withdrawing from methadone while staying here at Novus
but now my body needs time to adjust to all the good and
bad things this world has to offer me. It's like I can
see the light that guides our way through life but it
still is shining just out of reach. Once my mind,
body and soul can adjust and realize themselves then I
hope to grasp the light. The staff at
Novus helped me to realize this and for that I thank
them. Even
though I know I am strong enough to overcome my
obstacles with help it can only make me stronger. I've decided
that living is more important than just
maintaining.
I would especially like to thank the members of
your staff without their help and friendship I
definitely wouldn't have had as easy of a time of
withdrawing as I did. JJ, Montana,
Scott, Jessica and Patty,
DIABETES
In that same 2006 FDA
testimony, Dr. Tracy said, “Diabetes has
skyrocketed, has been linked to antidepressants, and blood sugar imbalances
have long been suspected as the cause of mania or bipolar. Anyone who has
witnessed someone in insulin shock would see the striking similarity to a
violent reaction to an antidepressant.”
JUST RELEASED DIABETES AND ANTIDEPRESSANTS STUDY
Most
people know that type 2 diabetics are unable to utilize their body’s insulin to
move blood sugar into the cells for energy.
Type 2 diabetes has dramatically increased in the past 30 years and now affects
nearly 21 million in the United
States.
Diabetes is a major cause of heart disease and stroke, as well as the
most common cause of blindness, kidney failure and amputations in U.S.
adults.
A new study shows a link between the use of
antidepressants and type 2 diabetes.
Lauren Brown, a researcher with the University of Alberta's
School of Public Health, studied the medical history of 2,400 people who were diagnosed with depression
and were taking antidepressants. What she found was the risk of diabetes almost
doubled for the patients who were using two types of therapies at the same
time, tricyclic antidepressants (TCAs) and selective serotonin reuptake
inhibitors (SSRIs). Brown says people are usually prescribed multiple
medications "if they have severe
depression or if they are having a problem finding the right therapy."
DIABETES AND CANCER
In addition to the problems of type 2
diabetes, a study published in Nature
Genetics points out that men who
have an elevated risk of type 2 diabetes have a new risk—prostate cancer. Researchers have now identified two genes
that have been found to be present in people with type 2 diabetes also appear
to be present in instances of prostate cancer.
WEIGHT
GAIN
For a long time, Dr. Tracy has been warning
that antidepressant and anti-psychotic drugs are causing obesity. Now other scientists are starting to release
their studies confirming Dr. Tracy’s comments.
Dr. David Lau, chair of the diabetes and
endocrine research group at the University
of Calgary and president
of Obesity Canada, says that the widespread use of psychiatric medications
among adults and children is making the obesity epidemic worse. He says that psychiatric
drug-related weight gain "is a huge
problem."
"You
can see patients gaining
DIABETES
In that same 2006 FDA
testimony, Dr. Tracy said, “Diabetes has
skyrocketed, has been linked to antidepressants, and blood sugar imbalances
have long been suspected as the cause of mania or bipolar. Anyone who has
witnessed someone in insulin shock would see the striking similarity to a
violent reaction to an antidepressant.”
JUST RELEASED DIABETES AND ANTIDEPRESSANTS STUDY
Most
people know that type 2 diabetics are unable to utilize their body’s insulin to
move blood sugar into the cells for energy.
Type 2 diabetes has dramatically increased in the past 30 years and now affects
nearly 21 million in the United
States.
Diabetes is a major cause of heart disease and stroke, as well as the
most common cause of blindness, kidney failure and amputations in U.S.
adults.
A new study shows a link between the use of
antidepressants and type 2 diabetes.
Lauren Brown, a researcher with the University of Alberta's
School of Public Health, studied the medical history of 2,400 people who were diagnosed with depression
and were taking antidepressants. What she found was the risk of diabetes almost
doubled for the patients who were using two types of therapies at the same
time, tricyclic antidepressants (TCAs) and selective serotonin reuptake
inhibitors (SSRIs). Brown says people are usually prescribed multiple
medications "if they have severe
depression or if they are having a problem finding the right therapy."
DIABETES AND CANCER
In addition to the problems of type 2
diabetes, a study published in Nature
Genetics points out that men who
have an elevated risk of type 2 diabetes have a new risk—prostate cancer. Researchers have now identified two genes
that have been found to be present in people with type 2 diabetes also appear
to be present in instances of prostate cancer.
WEIGHT
GAIN
For a long time, Dr. Tracy has been warning
that antidepressant and anti-psychotic drugs are causing obesity. Now other scientists are starting to release
their studies confirming Dr. Tracy’s comments.
Dr. David Lau, chair of the diabetes and
endocrine research group at the University
of Calgary and president
of Obesity Canada, says that the widespread use of psychiatric medications
among adults and children is making the obesity epidemic worse. He says that psychiatric
drug-related weight gain "is a huge
problem."
"You
can see patients gaining 10, 20, 30, 40 pounds," Lau says.
Writing in the March 8, 2008 issue of New Scientist, Harvard University
psychologist Paula Caplan says obesity among teens and younger children has risen
over the past 10 to 15 years, with a five-fold increase in prescriptions of
anti-psychotic drugs to those age groups, and that "children taking these
drugs are even more likely to gain weight than adults are."
She believes the widespread use of psychiatric
medications among adults and children is making the obesity epidemic worse.
“Yet
one culprit is rarely mentioned: the broad range of psychiatric drugs that can
cause substantial weight gain. They include drugs marketed as antidepressants
(such as amitriptyline, doxepin and imipramine), mood stabilisers (including
lithium and valproate) and antipsychotics (including clozapine, olanzapine and
chlorpromazine). After 10 years on lithium, for example, two-thirds of patients
put on around 10 kilograms. And in December 2006, The New York Times published an article based on internal
documents from the drug company Eli Lilly which indicated that it had
intentionally downplayed the side effects of olanzapine, which it sells as
Zyprexa. The company's data showed that
DIABETES
In that same 2006 FDA
testimony, Dr. Tracy said, “Diabetes has
skyrocketed, has been linked to antidepressants, and blood sugar imbalances
have long been suspected as the cause of mania or bipolar. Anyone who has
witnessed someone in insulin shock would see the striking similarity to a
violent reaction to an antidepressant.”
JUST RELEASED DIABETES AND ANTIDEPRESSANTS STUDY
Most
people know that type 2 diabetics are unable to utilize their body’s insulin to
move blood sugar into the cells for energy.
Type 2 diabetes has dramatically increased in the past 30 years and now affects
nearly 21 million in the United
States.
Diabetes is a major cause of heart disease and stroke, as well as the
most common cause of blindness, kidney failure and amputations in U.S.
adults.
A new study shows a link between the use of
antidepressants and type 2 diabetes.
Lauren Brown, a researcher with the University of Alberta's
School of Public Health, studied the medical history of 2,400 people who were diagnosed with depression
and were taking antidepressants. What she found was the risk of diabetes almost
doubled for the patients who were using two types of therapies at the same
time, tricyclic antidepressants (TCAs) and selective serotonin reuptake
inhibitors (SSRIs). Brown says people are usually prescribed multiple
medications "if they have severe
depression or if they are having a problem finding the right therapy."
DIABETES AND CANCER
In addition to the problems of type 2
diabetes, a study published in Nature
Genetics points out that men who
have an elevated risk of type 2 diabetes have a new risk—prostate cancer. Researchers have now identified two genes
that have been found to be present in people with type 2 diabetes also appear
to be present in instances of prostate cancer.
WEIGHT
GAIN
For a long time, Dr. Tracy has been warning
that antidepressant and anti-psychotic drugs are causing obesity. Now other scientists are starting to release
their studies confirming Dr. Tracy’s comments.
Dr. David Lau, chair of the diabetes and
endocrine research group at the University
of Calgary and president
of Obesity Canada, says that the widespread use of psychiatric medications
among adults and children is making the obesity epidemic worse. He says that psychiatric
drug-related weight gain "is a huge
problem."
"You
can see patients gaining 10, 20, 30, 40 pounds," Lau says.
Writing in the March 8, 2008 issue of New Scientist, Harvard University
psychologist Paula Caplan says obesity among teens and younger children has risen
over the past 10 to 15 years, with a five-fold increase in prescriptions of
anti-psychotic drugs to those age groups, and that "children taking these
drugs are even more likely to gain weight than adults are."
She believes the widespread use of psychiatric
medications among adults and children is making the obesity epidemic worse.
“Yet
one culprit is rarely mentioned: the broad range of psychiatric drugs that can
cause substantial weight gain. They include drugs marketed as antidepressants
(such as amitriptyline, doxepin and imipramine), mood stabilisers (including
lithium and valproate) and antipsychotics (including clozapine, olanzapine and
chlorpromazine). After 10 years on lithium, for example, two-thirds of patients
put on around 10 kilograms. And in December 2006, The New York Times published an article based on internal
documents from the drug company Eli Lilly which indicated that it had
intentionally downplayed the side effects of olanzapine, which it sells as
Zyprexa. The company's data showed that one-third of patients who have taken
the drug for a year gain at least 10 kilograms, and half of these gain at least
30 kilograms.”
Caplan is concerned that patients aren’t
being warned that these dangerous drugs may cause substantial weight gain—particularly
with the growing trend of prescribing multiple psychotrophic drugs at the same
time.
WEIGHT GAIN, ALZHEIMER’S AND DEMENTIA
A study of more than 6,000 adults by the
Kaiser Permanente Division of Research in Oakland, California found that people
who gained more weight during their 40’s had a greater risk of developing
dementia (deterioration of mental ability) or Alzheimer's in their 70's.
It
is becoming increasingly apparent that the drug companies are interested in
convincing all of us that we have “diseases” which require their products
because that is the way to increase their profits. When the drugs cause the side effects that
the drug companies know will occur, they will sell us other drugs for
this.
Professor David Light of the Center for Bioethics
stated, "Evidence over the past 40
years indicates that harm to patients from adverse side effects of medicines
exceed benefits: only 1 in 7 new drugs have offered substantial therapeutic
benefit over existing treatments. On the other hand, at least 30 percent bear
risks of serious adverse events.
This
benefit:harm ratio of 15:30 or 1:2 is made worse by medicines being widely
prescribed for unapproved indications, being prescribed in higher doses than
needed for their stated benefits, being prescribed to ever-wider populations as
industry-supported experts lower thresholds on guidelines, and being prescribed
to patients with higher risks of the adverse events involved. Each of these
widening uses reduces any benefit and produces more ill-health. The scale of
ill health is epidemic."
one-third of patients who have taken
the drug for a year gain at least 10 kilograms, and half of these gain at least
30 kilograms.”
Caplan is concerned that patients aren’t
being warned that these dangerous drugs may cause substantial weight gain—particularly
with the growing trend of prescribing multiple psychotrophic drugs at the same
time.
WEIGHT GAIN, ALZHEIMER’S AND DEMENTIA
A study of more than 6,000 adults by the
Kaiser Permanente Division of Research in Oakland, California found that people
who gained more weight during their 40’s had a greater risk of developing
dementia (deterioration of mental ability) or Alzheimer's in their 70's.
It
is becoming increasingly apparent that the drug companies are interested in
convincing all of us that we have “diseases” which require their products
because that is the way to increase their profits. When the drugs cause the side effects that
the drug companies know will occur, they will sell us other drugs for
this.
Professor David Light of the Center for Bioethics
stated, "Evidence over the past 40
years indicates that harm to patients from adverse side effects of medicines
exceed benefits: only 1 in 7 new drugs have offered substantial therapeutic
benefit over existing treatments. On the other hand, at least 30 percent bear
risks of serious adverse events.
This
benefit:harm ratio of 15:30 or 1:2 is made worse by medicines being widely
prescribed for unapproved indications, being prescribed in higher doses than
needed for their stated benefits, being prescribed to ever-wider populations as
industry-supported experts lower thresholds on guidelines, and being prescribed
to patients with higher risks of the adverse events involved. Each of these
widening uses reduces any benefit and produces more ill-health. The scale of
ill health is epidemic."
10, 20, 30, 40 pounds," Lau says.
Writing in the March 8, 2008 issue of New Scientist, Harvard University
psychologist Paula Caplan says obesity among teens and younger children has risen
over the past 10 to 15 years, with a five-fold increase in prescriptions of
anti-psychotic drugs to those age groups, and that "children taking these
drugs are even more likely to gain weight than adults are."
She believes the widespread use of psychiatric
medications among adults and children is making the obesity epidemic worse.
“Yet
one culprit is rarely mentioned: the broad range of psychiatric drugs that can
cause substantial weight gain. They include drugs marketed as antidepressants
(such as amitriptyline, doxepin and imipramine), mood stabilisers (including
lithium and valproate) and antipsychotics (including clozapine, olanzapine and
chlorpromazine). After 10 years on lithium, for example, two-thirds of patients
put on around 10 kilograms. And in December 2006, The New York Times published an article based on internal
documents from the drug company Eli Lilly which indicated that it had
intentionally downplayed the side effects of olanzapine, which it sells as
Zyprexa. The company's data showed that one-third of patients who have taken
the drug for a year gain at least 10 kilograms, and half of these gain at least
30 kilograms.”
Caplan is concerned that patients aren’t
being warned that these dangerous drugs may cause substantial weight gain—particularly
with the growing trend of prescribing multiple psychotrophic drugs at the same
time.
WEIGHT GAIN, ALZHEIMER’S AND DEMENTIA
A study of more than 6,000 adults by the
Kaiser Permanente Division of Research in Oakland, California found that people
who gained more weight during their 40’s had a greater risk of developing
dementia (deterioration of mental ability) or Alzheimer's in their 70's.
It
is becoming increasingly apparent that the drug companies are interested in
convincing all of us that we have “diseases” which require their products
because that is the way to increase their profits. When the drugs cause the side effects that
the drug companies know will occur, they will sell us other drugs for
this.
Professor David Light of the Center for Bioethics
stated, "Evidence over the past 40
years indicates that harm to patients from adverse side effects of medicines
exceed benefits: only 1 in 7 new drugs have offered substantial therapeutic
benefit over existing treatments. On the other hand, at least 30 percent bear
risks of serious adverse events.
This
benefit:harm ratio of 15:30 or 1:2 is made worse by medicines being widely
prescribed for unapproved indications, being prescribed in higher doses than
needed for their stated benefits, being prescribed to ever-wider populations as
industry-supported experts lower thresholds on guidelines, and being prescribed
to patients with higher risks of the adverse events involved. Each of these
widening uses reduces any benefit and produces more ill-health. The scale of
ill health is epidemic."
thank you very
much."
